Literature DB >> 3491944

Human leukocytic antigens in autoimmune sensorineural hearing loss.

C A Bowman, R A Nelson.   

Abstract

Susceptibility to many autoimmune diseases is associated with inheritance of certain Human Leukocytic Antigens (HLA), determinants which have become diagnostic or prognostic markers. In this study of HLA antigen frequencies among patients with autoimmune sensorineural hearing loss, 39 patients with this otologic disorder were typed for HLA-A, B, C, and DR antigens. A significant increase of Cw7 occurred in 51% of patients compared to 21% of 627 matched controls (relative risk, 3.95). Trends towards increased frequencies of Cw4, B35 and reduced frequency of DR4 were also observed. These data suggest a possible immunogenetic predisposition to this otologic disorder. The presence of Cw7 may facilitate the diagnosis of autoimmune sensorineural hearing loss.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491944     DOI: 10.1288/00005537-198701000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Vertigo, hearing loss, and tinnitus.

Authors:  S A Raza; J J Phillipps
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

2.  Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.

Authors:  S J Greenberg; K Fujihara; S M Selkirk; F Yu; T L Du; N Glenister; P Hohmann; M H Rickert; P O Spence; C E Miller; L D Jacobs
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease.

Authors:  Shresh Pathak; Lynda J Hatam; Vincent Bonagura; Andrea Vambutas
Journal:  J Clin Immunol       Date:  2013-08-03       Impact factor: 8.317

4.  Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3.

Authors:  Luigi F Bertoli; Dennis G Pappas; J Clayborn Barton; James C Barton
Journal:  BMC Immunol       Date:  2014-10-22       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.